Join our mailing list!
(Your shopping cart is empty)
Diane Publishing Books
Generic Drugs under Medicare: Part D Generic Drug Prices Declined Overall, but Some Had Extraordinary Price Increases
John E. Dicken (au)
Medicare is the largest public payer for prescription drugs, representing 29% of total retail prescription drug spending in 2014. Generic prescription drugs have been a source of cost savings for the U.S. health care system due to their lower costs relative to brand-name drugs. However, recent price increases of certain generics may limit cost savings. This report describes (1) how generic drug prices under Medicare Part D have changed over time; (2) the extent to which generic drugs under Medicare Part D experienced extraordinary price increases, the persistence of any increases, and their effect on benefit design; and (3) the factors that stakeholders identified as contributing to price changes. Tables and figures. This is a print on demand report.
Essential Tibetan Buddhism
Between Friends: Writing Women Celebrate Friendship
Office Computing Bible: Using Personal Computers at Work
Share your knowledge of this product with other customers...
Be the first to write a review
Diane Publishing Co
PO Box 617
Darby, PA 19023-0617
Become an Affiliate
Send Us Feedback
Copyright ï¿½ 2004 Diane Publishing Company. All Rights Reserved.